Endocyte, Inc. (ECYT) Stock Charts ECYT Home News Ratings Charts Warning: This security is no longer trading. Novartis successfully completes acquisition of Endocyte Endocyte, Inc. (ECYT): $23.99 0.01 (-0.04%) POWR Rating Get Rating Component Grades Growth Get Rating Value Get Rating Momentum NR Stability NR Sentiment Get Rating Quality NR Add ECYT to Watchlist Sign Up Industry: Biotech Industry NR Ranked in industry See All 'A' Rated Buy Stocks Endocyte, Inc. (ECYT) Performance Graph for POWR Ratings Endocyte, Inc. (ECYT) Interactive Chart ECYT Chart by TradingView Endocyte, Inc. (ECYT) Ratings History Chart Free access to the full ratings history for ECYT. Sign up now! Most Popular Stories View All • Will Stocks Continue to Rise...Or Time for Rug Pull? • 4 Software Stocks Primed for Major Upside in 2024 • 3 Pharma Stocks Primed for May Investment Opportunities • 3 Bargain Internet Stock Buys for Savvy Investors • 2 Paths for Stocks from Here View All Top stories Get Free Updates Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Subscribe Get Free Updates Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
